Recent

% | $
Quotes you view appear here for quick access.

Express Scripts Holding Company Message Board

  • jdpack2000 jdpack2000 Nov 6, 2012 2:08 PM Flag

    just downgraded

    e are lowering our EPS estimates $0.03 to $3.69 for 2012, and by $0.15 to $4.45 for 2013, reflecting the loss of UnitedHealthcare business in 2013, and likely in-group member attrition and low utilization rates amid a weak business climate. We are cutting our target price by $5 to $65, applying a peer P/E of 14.6X to our 2013 EPS forecast. Q3 EPS of $1.02, was $0.01 below our estimate. However, we still expect ESRX to generate annual EPS growth in the high teens in the years ahead, helped by ongoing synergies from the Medco acquisition and growth in its industry.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • S&P DOWNGRADES OPINION ON SHARES OF EXPRESS SCRIPTS TO BUY FROM STRONG
      BUY
      (S&P Capital IQ)
      We are lowering our EPS estimates $0.03 to $3.69 for 2012, and by $0.15 to $4.45 for 2013, reflecting the loss of UnitedHealthcare business in 2013, and likely in-group member attrition and low utilization rates amid a weak business climate. We are cutting our target price by $5 to $65, applying a peer P/E of 14.6X to our 2013 EPS forecast. Q3 EPS of $1.02, was $0.01 below our estimate. However, we still expect ESRX to generate annual EPS growth in the high teens in the years ahead, helped by ongoing synergies from the Medco acquisition and growth in its industry.

 
ESRX
73.62-0.11(-0.15%)May 2 4:00 PMEDT